Knoll Capital Management, LLC Diversified Active

CIK: 0001325083 · Show all filings

Period: Q1 2019 (← Previous) (Next →)

Filing Date: May 15, 2019

Total Value ($000): $131,596 (100.0% shares, 0.0% debt)

Holdings (17)

Biohaven Pharmactl Hldg Co L 29.3%
Value ($000) $38,593 Shares 749,815 Est. Cost $25.00 Unrealized
Corbus Pharmaceuticals HLDGS 26.3%
Value ($000) $34,652 Shares 4,985,870 Est. Cost $4.98 Unrealized
Abeona Therapeutics Inc 13.2%
Value ($000) $17,368 Shares 2,359,767 Est. Cost $4.97 Unrealized
KRYS Krystal Biotech Inc 5.3%
Value ($000) $6,909 Shares 209,986 Est. Cost $10.08 Unrealized +133.8%
Blackstone Group LP 4.1%
Value ($000) $5,350 Shares 153,000 Est. Cost $34.97 Unrealized
MO Altria Group Inc 3.9%
Value ($000) $5,169 Shares 90,000 Est. Cost $29.72 Unrealized 0.0%
DowDupont Inc 3.6%
Value ($000) $4,798 Shares 90,000 Est. Cost $53.31 Unrealized
ALDX Aldeyra Therapeutics Inc 3.3%
Value ($000) $4,371 Shares 484,096 Est. Cost $8.65 Unrealized -1.8%
KBA Kraneshares TR 2.3%
Value ($000) $3,061 Shares 96,000 Est. Cost $31.89 Unrealized
Electrocore Inc 2.1%
Value ($000) $2,778 Shares 396,825 Est. Cost $16.51 Unrealized
AVXL Anavex Life Sciences Corp 1.7%
Value ($000) $2,209 Shares 724,205 Est. Cost $3.56 Unrealized -33.0%
ENTX Entera Bio Ltd 1.6%
Value ($000) $2,057 Shares 475,540 Est. Cost $6.29 Unrealized -35.5%
Galmed Pharmaceuticals Ltd 1.3%
Value ($000) $1,684 Shares 206,099 Est. Cost $11.90 Unrealized
Eiger Biopharmaceuticals Inc 0.8%
Value ($000) $1,052 Shares 75,238 Est. Cost $9.85 Unrealized
Soligenix Inc. 0.6%
Value ($000) $767 Shares 837,800 Est. Cost $2.11 Unrealized
Molecular Templates 0.5%
Value ($000) $662 Shares 113,905 Est. Cost $4.04 Unrealized
Lipocine Inc New 0.1%
Value ($000) $116 Shares 50,000 Est. Cost $1.30 Unrealized